Black Rock Inc. Collegium Pharmaceutical, Inc Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Black Rock Inc. holds 5,865,899 shares of COLL stock, worth $185 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

5,865,899

Previous 5,786,993 1.36%

Holding current value

$185 Million

Previous $178 Million 27.84%

% of portfolio

0.01%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$31.23 - $40.91 $2.46 Million - $3.23 Million	78,906 Added 1.36%	5,865,899 $228 Million
Q4 2023 Feb 13, 2024	SELL	$21.16 - $30.8 $9.61 Million - $14 Million	-453,971 Reduced 7.27%	5,786,993 $178 Million
Q3 2023 Nov 13, 2023	BUY	$21.23 - $24.28 $3.45 Million - $3.95 Million	162,645 Added 2.68%	6,240,964 $139 Million
Q2 2023 Aug 11, 2023	BUY	$21.06 - $24.0 $5.61 Million - $6.39 Million	266,330 Added 4.58%	6,078,319 $131 Million
Q1 2023 May 12, 2023	BUY	$23.0 - $29.88 $1.83 Million - $2.38 Million	79,724 Added 1.39%	5,811,989 $139 Million

Q4 2022 Feb 13, 2023	SELL	$16.14 - $23.55 $175,361 - $255,870	-10,865 Reduced 0.19%	5,732,265 $133 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $20.1 $1.42 Million - $1.85 Million	92,014 Added 1.63%	5,743,130 $92 Million
Q2 2022 Aug 12, 2022	SELL	$14.22 - $20.88 $941,207 - $1.38 Million	-66,189 Reduced 1.16%	5,651,116 $100 Million
Q1 2022 May 12, 2022	BUY	$17.2 - $22.5 $1.47 Million - $1.93 Million	85,645 Added 1.52%	5,717,305 $116 Million
Q4 2021 Feb 10, 2022	BUY	$17.5 - $21.35 $76,160 - $92,915	4,352 Added 0.08%	5,631,660 $105 Million
Q3 2021 Nov 09, 2021	SELL	$17.75 - $25.39 $697,912 - $998,309	-39,319 Reduced 0.69%	5,627,308 $111 Million
Q2 2021 Aug 11, 2021	BUY	$21.74 - $25.28 $123 Million - $143 Million	5,666,627 New	5,666,627 $134 Million

Others Institutions Holding COLL

# of Institutions

232

Shares Held

39.5M

Call Options Held

104K

Put Options Held

15.4K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.08B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account